Panel Discussion & Q&A: Advancing the Biomarker Journey with CDx Development

Time: 7:25 pm
day: Agenda: From Idea to Commercialization: Advancing the Biomarker Development Journey


– Discussing proven strategies for early phase development of prototype CDx in clinical trials

– Discovering how to approach new technologies for CDx development including multiplex IHC, flow cytometry and gene signatures

– Addressing different ways to ensure availability of novel CDx assays following drug approval